Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ainos Inc (NQ: AIMD )

0.4400 -0.0400 (-8.33%)
Streaming Delayed Price Updated: 11:34 AM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ainos Inc

< Previous 1 2 3 4 5 6 7 Next >
PLUG Stock Alert: Plug Power Pops on Analyst Upgrade
Plug Power (PLUG) stock is getting a boost on Friday after Northland Securities analysts upgraded the hydrogen fuel cell company's shares. 
Via InvestorPlace
Why Is Leslies (LESL) Stock Down 36% Today?
Leslies (LESL) stock is falling on Friday after the company released its preliminary earnings report for the third quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Is Theseus Pharmaceuticals (THRX) Stock Down 68% Today?
Theseus Pharmaceuticals (THRX) stock is falling hard on Friday after the company announced poor results from a Phase 1/2 clinical trial. 
Via InvestorPlace
Why Is Ainos (AIMD) Stock Up 82% Today?
Ainos (AIMD) stock is on the rise Friday with heavy trading despite a lack of news from the medical technologies company. 
Via InvestorPlace
Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday. 
Via Benzinga
Ainos Issues Mid-Year Business Update Letter to Shareholders
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Ainos Provides Insights Into Its AI Nose Technology
Via ACCESSWIRE
Ainos Completes VELDONA Pet Line-Up by Launching New VELDONA Pet Shiny and Slim in Push Towards $20M Revenue Target
Via ACCESSWIRE
Ainos Launches New VELDONA Pet Lohas and Soothing Health Supplements, Catalyzing Its Drive to $20M Sales Target
Via ACCESSWIRE
Ainos Launches VELDONA Pet Cytoprotein Health Supplement Targeting $20M in Sales
Via ACCESSWIRE
Ainos Appoints Amanda Sung as New Chief Financial Officer
Via ACCESSWIRE
Ainos Reports First Quarter 2023 Financial Results
Via ACCESSWIRE
Ainos Reports Fourth Quarter and Full Year 2022 Financial Results
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Ainos Signs Agreement Establishing Topmed as Exclusive Distributor of VELDONA Animal Health Supplements in Taiwan
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
S&P 500 Rises 1%; Crude Oil Down Over 4%
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 1.5% on Tuesday. The Dow traded up 0.40% to 31,945.39 while the NASDAQ rose 1.58% to 11,365.53. The S&P 500,... 
Via Benzinga
Ainos and Tah-An Sign MoU to Explore Manufacture of VELDONA Animal Investigational New Drug
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why RAPT Therapeutics Shares Are Trading Lower By Over 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Ainos, Inc. (NASDAQ: AIMD) shares jumped 69.3% to $1.27 after the company announced it signed a Memorandum of Understanding with Merdury Biopharmaceutical to jointly explore and develop a... 
Via Benzinga
Nasdaq Jumps Over 200 Points; GitLab Shares Plummet
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 400 points on Tuesday. The Dow traded up 1.30% to 32,234.35 while the NASDAQ rose 2.07% to 11,421.23. The S&P 500,... 
Via Benzinga
Ainos (NASDAQ: AIMD) Enters MoU with Merdury to Explore Phase 3 Study of VELDONA
Ainos, Inc. (NASDAQ: AIMD) is engaged as a diversified medical technology company, which is focused on developing innovative point-of-care testing 
Via Spotlight Growth
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Ainos and Merdury Sign MoU to Explore Phase 3 Study of VELDONA Drug Candidate for Treatment of Oral Warts in HIV-Seropositive Patients
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Ainos Announces US$3 Million Convertible Notes Private Placement
Via ACCESSWIRE
Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.